MedRhythms Launches Clinical Trial of Digital Therapeutic in Parkinson’s Disease and Expands Pipeline to Aging

MedRhythms has announced the initiation of a multi-site clinical trial, in collaboration with Boston University, of its pipeline asset MR-005 in Parkinson’s disease as well as the expansion of the company’s pipeline into aging with the development of its Aging Scientific Advisory Board.